Ablynx Enters €3.9bn Acquisition Deal With Sanofi
The deal comes after Ablynx rejected the second acquisition proposal made by Denmark’s Novo Nordisk earlier this month for €2.5bn,...
Danish Researchers Create New Approach To Make QR-Coded Medicines
University of Copenhagen pharmacy department assistant professor Natalja Genina said: “This technology is promising, because the medical drug can be...
Dr Reddy’s posts better than expected Q3 numbers but concerns remain
There were two positive developments at Dr Reddy's that were hard to miss when the company's CFO Saumen Chakraborty and...
Blood vessel-on-a-chips show anti-cancer drug effects in human cells
Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology...
Optimismm of POMALYST omit positive results for treating a malicious disease: Celegne corporation
SMM evaluated the efficacy and safety of POMALYST/IMNOVID (pomalidomide) plus bortezomib and low-dose dexamethasone (PVd) versus bortezomib and low-dose dexamethasone...
Alexion Appoints Judith A. Reinsdorf, J.D., To Its Board Of Directors
Alexion Pharmaceuticals, Inc. announced that Judith A. Reinsdorf, J.D., has been appointed to the Company’s Board of Directors. Ms. Reinsdorf...
Kanuma ensuressurvival from Lysosomal Acid Lipse Deficiency; A Liver Disease
Alexion Pharmaceuticals, Inc. announced that the combined interim data from two ongoing open-label studies, VITAL and CL-08, show a 3-year...
GSK’S B vaccine prevents harmful disease among children; U.S FDA applauds
GlaxoSmithKline plc announced that it has received Breakthrough Therapy Designation from the U.S. FDA for its meningitis B vaccine Bexsero...
Janssen Pierce To Globally Collabrate With Theravance Biopharma For Oral, Pan-Jak Inhibitor Drug Candidate For The Treatment Of Inflammatory Bowel Disease
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today their entry into a worldwide collaboration with an affiliate of...
Roche’s TECENTRIQ®and Avastin® reduced the risk of disease worsening or death by 26 percent in certain advanced kidney cancer cases
Roche announced results from the positive Phase III IMmotion151 study of TECENTRIQ® (atezolizumab) and Avastin® (bevacizumab) as a first-line treatment...
Latest News
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.